MedPath

Evaluation of Isoniazide 300mg for Latent Tuberculosis Treatment

Not Applicable
Conditions
atent tuberculosis.
Registration Number
RBR-2wsdt6
Lead Sponsor
niversidade Federal do Espirito Santo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

All individuals over 18 years of age with indication for ILTB treatment

Exclusion Criteria

Individuals whose case index is a multiresistant and extremely resistant case, as well as those individuals who were transferred from the original center after two or more weeks of treatment initiation beyond the individuals in the prison system will be excluded.In addition, people over 80 years old will be excluded.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath